“Today, we welcome the new era of intravascular imaging in intracranial circulation with this new technology,” said Matt Gounis PhD, Professor at the UMass Medical School Department of Radiology and Director of New England Center for Stroke Research. “Revolutions in neurointerventional imaging, from the discovery of x-rays over 120 years ago, to 3-dimensional imaging in the angiography suite 20 years ago, occur roughly once in a generation. The work demonstrated by Dr Pereira and his team in these first human cases is profound – direct imaging of the pathology and its relationship to devices transforms treatment decisions, and the fundamental understanding of cerebrovascular pathology.”

​“Gentuity is committed to accelerating the improvement of neurovascular patient care. With our proprietary neuro intravascular imaging system and AI data platform, we are able to work closely with our clinical and preclinical partners to collaborate and enhance our understandings and patient care together,” said David Kolstad, CEO of Gentuity, LLC. “We have been very fortunate to work with leaders in the field of neurointervention including Dr Vitor Mendes Pereira, Dr Ajit Puri, Dr Matt Gounis, Dr Pedro Lylyk, Dr Demetrius Lopes, Dr Ricardo Hanel, Dr Conrad Liang, Dr Vaia Anagnostakou and others to reach this important milestone.”

About Gentuity
Gentuity, an advanced imaging and AI firm based in Massachusetts, is dedicated to developing next-generation intravascular devices that enable fundamental transformation of cardiovascular and neurovascular patient care. The Gentuity system is a proprietary platform, incorporating AI, that aims to enhance procedural success and clinical decision making. Gentuity strives to bring the benefits of high-resolution intravascular imaging to more patients and hospitals around the world.

Back to HCB News

CT Homepage